<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no" />
        <title>Full STD Tx Guidelines</title>
        <link href="../jquery-mobile/jquery.mobile.theme-1.3.1.min.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.f.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.j.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.structure-1.3.1.min.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/full.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/recreated_tables.css" rel="stylesheet" type="text/css"/>
        <script src="../jquery-mobile/jquery-1.9.1.min.js" type="text/javascript"></script>
        <script src="../../jquery-customization.js" type="text/javascript"></script>
        <script src="../jquery-mobile/jquery.mobile-1.3.1.min.js" type="text/javascript"></script>
        <script src="../../cordova-2.7.0.js" type="text/javascript" charset="utf-8"></script>
        <script src="../assets/js/metrics.js" type="text/javascript" charset="utf-8"></script>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g415" data-theme="d">
            <div data-role="header" data-id="guidelines-header" data-theme="j" data-position="fixed">
                <a href="lv-409.html" data-role="button" data-iconshadow="false" data-corners="false" data-theme="reset" data-transition="fade" class="back_button" role="button" aria-label="back"></a>
                <h1>Full STD Tx Guidelines</h1>
	            <a href="../menu.html" data-role="button" data-theme="reset" data-iconshadow="false" data-corners="false" class="menu_button ui-btn-right" role="button" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-0.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-409.html" >References</a><span class="carrot"> > </span>References 251-300
            </div>
            </br><h2 id="sigil_toc_id_415">
 References 251-300
</h2>
<p>
 251. Fung M, Scott KC, Kent CK, et al. Chlamydial and gonococcal reinfection&nbsp;among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007;83:304&ndash;9.
</p>
<p>
 252. Kissinger PJ, Reilly K, Taylor SN, et al. Early repeat Chlamydia trachomatis&nbsp;and Neisseria gonorrhoeae infections among heterosexual men. Sex Transm Dis 2009;36:498&ndash;500.
</p>
<p>
 253. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008;19:676&ndash;9.
</p>
<p>
 254. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium&nbsp;following azithromycin therapy. PLoS One 2008;3:e3618.
</p>
<p>
 255. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968;5:492&ndash;518.
</p>
<p>
 256. Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003;170:818&ndash;22.
</p>
<p>
 257. Lusk MJ, Konecny P. Cervicitis: a review. Curr Opin Infect Dis 2008;21:49&ndash;55.
</p>
<p>
 258. Marrazzo JM, Martin DH. Management of women with cervicitis. Clin Infect Dis 2007;44 (Suppl 3):S102&ndash;10.
</p>
<p>
 259. Korte JE, Baseman JB, Cagle MP, et al. Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol 2006;55:265&ndash;75.
</p>
<p>
 260. Gaydos C, Maldeis NE, Hardick A, et al. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 2009;36:598&ndash;606.
</p>
<p>
 261. Schwebke JR, Weiss HL. Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis 2002;29:59&ndash;64.
</p>
<p>
 262. Marrazzo JM, Wiesenfeld HC, Murray PJ, et al. Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 2006;193:617&ndash;24.
</p>
<p>
 263. Haggerty CL, Totten PA, Astete SG, et al. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory&nbsp;disease. Infect Dis Obstet Gynecol 2006; Article ID 30184:1&ndash;5.
</p>
<p>
 264. Steinhandler L, Peipert JF, Heber W, et al. Combination of bacterial vaginosis and leukorrhea as a predictor of cervical chlamydial or gonococcal&nbsp;infection. Obstet Gynecol 2002;99:603&ndash;7.
</p>
<p>
 265. Geisler WM, Yu S, Venglarik M, et al. Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections.&nbsp;Sex Transm Infect 2004;80:401&ndash;5.
</p>
<p>
 266. Manhart LE. Has the time come to systematically test for Mycoplasma genitalium? Sex Transm Dis 2009;36:607&ndash;8.
</p>
<p>
 267. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009;36:478&ndash;89.
</p>
<p>
 268. Coleman JS, Hitti J, Bukusi EA, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007;21:755&ndash;9.
</p>
<p>
 269. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008;35:946&ndash;59.
</p>
<p>
 270. Mcclelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis&nbsp;is associated with decreased cervical shedding of HIV-1. AIDS 2001;15:105&ndash;10.
</p>
<p>
 271. Meyers DS, Halvorson H, Luckhaupt S. Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2007;147:135&ndash;42.
</p>
<p>
 272. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory&nbsp;disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362&ndash;6.
</p>
<p>
 273. Kamwendo F, Forslin L, Bodin L, et al. Decreasing incidences of gonorrhea-and chlamydia-associated acute pelvic inflammatory disease: a 25-year study from an urban area of central Sweden. Sex Transm Dis 1996;23:384&ndash;91.
</p>
<p>
 274. Gift TL, Blake DR, Gaydos CA, et al. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2008;35(11 Suppl):S51&ndash;60.
</p>
<p>
 275. Gift TL, Gaydos CA, Kent CK, et al. The program cost and cost-effectiveness&nbsp;of screening men for chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis 2008;35(11 Suppl):S66&ndash;75.
</p>
<p>
 276. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;32:725&ndash;8.
</p>
<p>
 277. Doshi JS, Power J, Allen E. Acceptability of chlamydia screening using self-taken vaginal swabs. Int J STD AIDS 2008;19:507&ndash;9.
</p>
<p>
 278. Schachter J, Moncada J, Liska S, et al. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008;35:637&ndash;42.
</p>
<p>
 279. Mimiaga MJ, Mayer KH, Reisner SL, et al. Asymptomatic gonorrhea and chlamydial infections detected by nucleic acid amplification tests among Boston area men who have sex with men. Sex Transm Dis 2008;35:495&ndash;8.
</p>
<p>
 280. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol 2010;48:1827&ndash;32.
</p>
<p>
 281. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J Clin Microbiol 2009;47:902&ndash;7.
</p>
<p>
 282. Chernesky M, Freund GG, Hook E, III, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays. J Clin Microbiol 2007;45:2434&ndash;8.
</p>
<p>
 283. Geisler WM, Wang C, Morrison SG, et al. The natural history&nbsp;of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008;35:119&ndash;23.
</p>
<p>
 284. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002;29:497&ndash;502.
</p>
<p>
 285. Bernstein KT, Stephens SC, Barry PM, et al. Chlamydia trachomatis&nbsp;and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Clin Infect Dis 2009;49:1793&ndash;7.
</p>
<p>
 286. Dunne EF, Chapin JB, Rietmeijer CA, et al. Rate and predictors of repeat Chlamydia trachomatis infection among men. Sex Transm Dis 2008;35(11 Suppl):S40&ndash;4.
</p>
<p>
 287. Kjaer HO, Dimcevski G, Hoff G, et al. Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks&rsquo; prospective follow up study. Sex Transm Infect 2000;76:169&ndash;72.
</p>
<p>
 288. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001;28:117&ndash;123.
</p>
<p>
 289. Jacobson GF, Autry AM, Kirby RS, et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001;184:1352&ndash;4.
</p>
<p>
 290. Kacmar J, Cheh E, Montagno A, et al. A randomized trial of azithromycin&nbsp;versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001;9:197&ndash;202.
</p>
<p>
 291. Rahangdale L, Guerry S, Bauer HM, et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006;33:106&ndash;110.
</p>
<p>
 292. Hammerschlag MR, Gelling M, Roblin PM, et al. Treatment of neonatal&nbsp;chlamydial conjunctivitis with azithromycin. Pediatr Infect Dis J 1998;17:1049&ndash;50.
</p>
<p>
 293. Weinstock H, Berman S, Cates W, Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6&ndash;10.
</p>
<p>
 294. Lyss SB, Kamb ML, Peterman TA, et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually&nbsp;transmitted disease clinics in the United States. Ann Intern Med 2003;139:178&ndash;85.
</p>
<p>
 295. Sathia L, Ellis B, Phillip S, et al. Pharyngeal gonorrhoea&mdash;is dual therapy the way forward? Int J STD AIDS 2007;18:647&ndash;8.
</p>
<p>
 296. Golden M, Kerani R, Shafii T, Whittington W, Holmes K. Does azithromycin co-treatment enhance the efficacy of oral cephalosporins for pharyngeal gonorrhea? Presented at: 18th International Society for STD Research (ISSTDR) Conference, London, UK, June 2009.
</p>
<p>
 297. Workowski KA, Berman SM, Douglas JM, Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med 2008;148:606&ndash;13.
</p>
<p>
 298. Tapsall JW. What management is there for gonorrhea in the postquinolone&nbsp;era? Sex Transm Dis 2006;33:8&ndash;10.
</p>
<p>
 299. CDC. Update to CDC&rsquo;s sexually transmitted diseases treatment guidelines,&nbsp;2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR 2007;56:332&ndash;6.
</p>
<p>
 300. Tapsall J, Read P, Carmody C, et al. Two cases of failed ceftriaxone treatment&nbsp;in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol 2009;58(Pt 5):683&ndash;7.
</p>

            </div>
            <script type="text/javascript">
                $('#g415').on('pageshow', function (event, ui) {
                    document.addEventListener("deviceready", function(){
                        trackFullGuidelinesPageView('415');
                                                },true);
                });
            </script>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

